Meet-the-Professor Session:
189. Updates from the Antibacterial Resistance Leadership Group
Saturday, October 6, 2018: 7:15 AM-8:15 AM
Room: W 2002

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • define elements of a pragmatic clinical trial
  • discuss how host gene expression-based diagnostics distinguish bacterial and viral infection
  • list three future challenges of antimicrobial drug resistance

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Lab personnel, Medical students and residents, Members-in-training, Microbiologists, Pharmacists, Researchers, Scientists

Tracks: Transplant ID, Trainee, Pediatric ID, Investigative ID, Global ID, Epidemiology and Infection Control, Adult ID


Moderators:  Cesar Arias, MD, PhD, FIDSA, University of Texas McGovern Medical School and Henry F. Chambers, MD, University of California, San Francisco General Hospital

CME Credits: Maximum of 1.00 hours of AMA PRA Category 1 Credit™

Disclosures:

C. Arias, Merck & Co., Inc.: Grant Investigator , Research support . MeMed: Grant Investigator , Research support . Allergan: Grant Investigator , Research support .

H. F. Chambers, None

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.